Haematology News

For decades the standard treatment for patients with advanced Hodgkin lymphoma has been combination chemotherapy with either ABVD or escalated BEACOPP. Approximately 5 years ago a randomised trial showed that brentuximab vedotin (an antibody conjugate) combined with AVD compared with ABVD improved overall survival in adults with Hodgkin lymphoma. The results of the recent SWOG … Read more

Whilst access to CAR-T therapy is only available by entry into clinical trials in the UK currently, recent results of ciltacabtagene autoleucel (also known as cilta-cel and Carvykit) has been shown to be “remarkably effective” in the treatment of myeloma. The results presented at the ASCO meeting and published in the New England Journal of … Read more